Colorectal Cancer Alliance Appoints Avi Benaim to Board of Directors
June 29, 2018 11:08 ET | Colorectal Cancer Alliance
Washington, D.C., June 29, 2018 (GLOBE NEWSWIRE) -- National non-profit the Colorectal Cancer Alliance today announced the appointment of Avi Benaim, Founder and President of A.B.E. Networks, to its...
Colorectal Cancer Alliance Announces Up To $775,000 In Available Research Funding
May 14, 2018 10:37 ET | Colorectal Cancer Alliance
Washington, D.C., May 14, 2018 (GLOBE NEWSWIRE) -- The Colorectal Cancer Alliance (the Alliance) has announced up to $775,000 in available funding for research in young-onset colorectal cancer,...
american-health-council-logo-210x126.jpg
Michael Tempel, MD, is Elected to the American Health Council’s Board of Physicians
January 09, 2018 10:20 ET | American Health Council
NEW YORK, Jan. 09, 2018 (GLOBE NEWSWIRE) -- Michael Tempel, MD, has been elected to the American Health Council’s Board of Physicians. Dr. Tempel utilizes his expertise as a General Surgeon for the...
GMILogo_Vertical-Gradient.png
Carcinoembryonic Antigen Market to hit $2.7bn by 2023: Global Market Insights, Inc.
April 20, 2017 06:30 ET | Global Market Insights, Inc
Ocean View, Delaware, April 20, 2017 (GLOBE NEWSWIRE) -- The research report “Carcinoembryonic Antigen (CEA) Market Size By Application (Colorectal, Pancreatic, Ovarian, Breast, Thyroid Cancer),...
DareBio_Stacked_Fullcolor_RGB.jpg
Cerulean Reports Third-Quarter 2014 Corporate Highlights and Financial Results
November 13, 2014 16:06 ET | Daré Bioscience, Inc.
CAMBRIDGE, Mass., Nov. 13, 2014 (GLOBE NEWSWIRE) -- Cerulean Pharma Inc. (Nasdaq:CERU), a leader in Dynamic Tumor Targeting™, today provided an update on corporate activities during the quarter...